Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas

View ORCID ProfileAlberto Aleta, David Martín-Corral, View ORCID ProfileMichiel A. Bakker, View ORCID ProfileAna Pastore y Piontti, View ORCID ProfileMarco Ajelli, View ORCID ProfileMaria Litvinova, View ORCID ProfileMatteo Chinazzi, View ORCID ProfileNatalie E. Dean, View ORCID ProfileM. Elizabeth Halloran, View ORCID ProfileIra M. Longini Jr., View ORCID ProfileAlex Pentland, View ORCID ProfileAlessandro Vespignani, View ORCID ProfileYamir Moreno, View ORCID ProfileEsteban Moro
doi: https://doi.org/10.1101/2020.12.15.20248273
Alberto Aleta
1Institute for Scientific Interchange Foundation, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alberto Aleta
David Martín-Corral
2Department of Mathematics and GISC, Universidad Carlos III de Madrid, Leganés, Spain
3Zensei Technologies S.L., Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiel A. Bakker
4Connection Science, Institute for Data Science and Society, MIT, Cambridge, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michiel A. Bakker
Ana Pastore y Piontti
5Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana Pastore y Piontti
Marco Ajelli
6Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA
5Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco Ajelli
Maria Litvinova
6Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Litvinova
Matteo Chinazzi
5Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matteo Chinazzi
Natalie E. Dean
7Department of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalie E. Dean
M. Elizabeth Halloran
8Biostatistics, Bioinformatics, and Epidemiology Program, Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
9Department of Biostatistics, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Elizabeth Halloran
Ira M. Longini Jr.
7Department of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ira M. Longini Jr.
Alex Pentland
4Connection Science, Institute for Data Science and Society, MIT, Cambridge, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alex Pentland
Alessandro Vespignani
5Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA
1Institute for Scientific Interchange Foundation, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alessandro Vespignani
  • For correspondence: alexves@gmail.com yamir.moreno@gmail.com esteban.moroegido@gmail.com
Yamir Moreno
10Institute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Spain
11Department of Theoretical Physics, Faculty of Sciences, University of Zaragoza, Spain
1Institute for Scientific Interchange Foundation, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yamir Moreno
  • For correspondence: alexves@gmail.com yamir.moreno@gmail.com esteban.moroegido@gmail.com
Esteban Moro
2Department of Mathematics and GISC, Universidad Carlos III de Madrid, Leganés, Spain
4Connection Science, Institute for Data Science and Society, MIT, Cambridge, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Esteban Moro
  • For correspondence: alexves@gmail.com yamir.moreno@gmail.com esteban.moroegido@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Detailed characterizations of SARS-CoV-2 transmission risk across different social settings can inform the design of targeted and less disruptive non-pharmaceutical interventions (NPI), yet these data have been lacking. Here we integrate real-time, anonymous and privacy-enhanced geolocalized mobility data with census and demographic data in the New York City and Seattle metropolitan areas to build a detailed agent-based model of SARS-CoV-2 transmission. The aim is to estimate where, when, and how many transmission events happened in those urban areas during the first wave of the pandemic. We estimate that most infections (80%) are produced by a small number of people (27%), and that about 10% of events can be considered super-spreading events (SSEs), i.e. generating more than eight secondary infections. Although mass gatherings present an important risk for future SSEs, we find that the bulk of transmission in the first wave occurred in smaller events at settings like workplaces, grocery stores, or food venues. We also observe that places where the majority of transmission and SSEs happened changed during the pandemic and are different across cities, a signal of the large underlying behavioral component underneath them. Our results demonstrate that constant real-time tracking of transmission events is needed to create, evaluate, and refine more effective and localized measures to contain the pandemic.

Competing Interest Statement

M.E.H. reports grants from the National Institute of General Medical Sciences during the conduct of the study; M.A. received research funding from Seqirus; A.V. reports grants and personal fees from Metabiota, Inc., outside of the submitted work; M.C. and A.PyP report grants from Metabiota, Inc., outside of the submitted work. The authors declare no other relationships or activities that could appear to have influenced the submitted work.

Funding Statement

N.E.D., I.M.L., MEH, A.PyP. and A.V. acknowledge the support of NIH/NIAID R56-AI148284. M.C. and A.V. acknowledge support from Google Cloud Healthcare and Life Sciences Solutions via the GCP research credits program. E.M. acknowledges partial support by MINECO (FIS2016-78904-C3-3-P and PID2019-106811GB-C32). Y.M. acknowledges partial support from the Government of Aragon and FEDER funds, Spain through grant E36-20R (FENOL), and by MINECO and FEDER funds (FIS2017-87519-P). A.A. and Y.M. acknowledge support from Banco Santander (Santander-UZ 2020/0274) and Intesa Sanpaolo Innovation Center. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

MIT Committee on the Use of Humans as Experimental Subjects. COUHES Exemption number #1812635935

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study is available from Cuebiq through their COVI19 collaborative, but restrictions apply to the availability of these data, which were used under licenses for the current study, and so are not publicly available. Aggregated data used in the models are however available from the authors upon reasonable request and permission of Cuebiq. Other data used comes from the American Community Survey (5-year) from the Census.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 17, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas
Alberto Aleta, David Martín-Corral, Michiel A. Bakker, Ana Pastore y Piontti, Marco Ajelli, Maria Litvinova, Matteo Chinazzi, Natalie E. Dean, M. Elizabeth Halloran, Ira M. Longini Jr., Alex Pentland, Alessandro Vespignani, Yamir Moreno, Esteban Moro
medRxiv 2020.12.15.20248273; doi: https://doi.org/10.1101/2020.12.15.20248273
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas
Alberto Aleta, David Martín-Corral, Michiel A. Bakker, Ana Pastore y Piontti, Marco Ajelli, Maria Litvinova, Matteo Chinazzi, Natalie E. Dean, M. Elizabeth Halloran, Ira M. Longini Jr., Alex Pentland, Alessandro Vespignani, Yamir Moreno, Esteban Moro
medRxiv 2020.12.15.20248273; doi: https://doi.org/10.1101/2020.12.15.20248273

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)